COVID-19 ‘vaccine’ drugs are modified mRNA gene therapy products. So, why did the FDA assign the review and recommendation responsibilities to the Vaccines and Related Biological Products Committee (VRBPAC) instead of the Cellular Tissue and Gene Therapy Advisory Committee (CTGTAC)? CTGTAC was the logical FDA advisory committee for such a […]
Report 96: mRNA COVID-19 Shots – ‘Vaccines’ or Gene Therapy Products? – Part 2
When considering a drug for emergency use authorization (EUA), the Food and Drug Administration (FDA) selects an internal advisory committee to review information and data submitted to the FDA by the pharmaceutical company about its new drug. These influential FDA advisory committees, based on that information and data, make recommendations […]
Progressive Supranuclear Palsy, a Neurological Disorder Described as “Parkinson’s on Steroids,” Following Injection of COVID-19 Gene Therapy Products
https://www.nbcnews.com/video/rep-wexton-announces-she-won-t-seek-reelection-after-new-health-diagnosis-193236549608 Central Nervous System: Anatomic-Function Correlation The brain is the most complicated organ by far. Pathological processes affect different areas of the nervous system which produce diverse and profound effects, some of which are outlined in the neurological diseases presented below. We know from Dr. Arne Burkhardt’s foundational work […]
Report 85: “The Underlying Pathology of Spike Protein Biodistribution in People That Died Post COVID-19 Vaccination” – Dr. Arne Burkhardt
The Scientific and Medical Advisory Committee hosted a meeting with special guest speaker Professor Arne Burkhardt. Dr. Arne Burkhardt Compiled and edited by Robert W. Chandler MD MBA* *A transcript was produced then edited with a diligent effort to leave the meaning unchanged. My additions are in italics. […]
From Clinical Trials to Histopathological Analysis: Evidence Shows COVID-19 “Vaccine” Products in Widespread Distribution Have Detrimental Effects on the Heart.
1. Cardiovascular warning signs were present in clinical trial subjects at six months. The cohort that received Pfizer’s BNT162b2 had more cardiac deaths than the non-BNT162b2 group. https://www.preprints.org/manuscript/202309.0131/v1 2. Pfizer document 3.5.6 indicates autoimmunity as the etiology (cause) of myopericarditis following BNT162b2 vaccination. 3. The government warning […]